Skip to main content

Articles

Page 9 of 32

  1. Patients treated with neoadjuvant chemotherapy (NACT) for advanced high-grade serous ovarian carcinoma (HGSC) have a higher rate and shorter time to platinum-resistant recurrence compared to patients treated w...

    Authors: Zibi Marchocki, Alicia Tone, Carl Virtanen, Richard de Borja, Blaise Clarke, Theodore Brown and Taymaa May
    Citation: Journal of Ovarian Research 2022 15:50
  2. Accumulated studies have provided controversial evidences of expression patterns and prognostic value of the GATA family in human ovarian cancer. In the present study, we accessed the distinct expression and prog...

    Authors: Quan Zhou, Huai-jie Yang, Man-zhen Zuo and Ya-ling Tao
    Citation: Journal of Ovarian Research 2022 15:49
  3. Taxol resistance in serous ovarian cancer is responsible for its poor prognosis, yet the underlying mechanism is still poorly understood. Thus, we probed the mechanism of Taxol resistance in serous ovarian can...

    Authors: Yuqing Shen, Hui Lin, Kelie Chen, Wanzhong Ge, Dajing Xia, Yihua Wu and Weiguo Lu
    Citation: Journal of Ovarian Research 2022 15:48
  4. The Ayurvedic system of medicine mentions the use of seeds of Bryonopsis laciniosa (L.) Naud. (also known as Shivlingi due to their unique structure resembling a ‘Shivling’) for treating sexual dysfunction, impai...

    Authors: Acharya Balkrishna, Pradeep Nain, Monali Joshi, Brijesh Kumar and Anurag Varshney
    Citation: Journal of Ovarian Research 2022 15:46
  5. Despite several initiatives by research groups, regulatory authorities, and scientific associations to engage citizens/patients in clinical research, there are still obstacles to participation. Among the main ...

    Authors: Paola Mosconi, Anna Roberto, Nicoletta Cerana, Nicoletta Colombo, Florence Didier, Maurizio D’Incalci, Domenica Lorusso and Fedro Alessandro Peccatori
    Citation: Journal of Ovarian Research 2022 15:45
  6. Currently, there is no universal criteria for the trigger time of controlled ovarian hyperstimulation (COH), especially with the emerging depot GnRH agonist protocol. It is challenging to explore an indicator ...

    Authors: Houming Su, Youhua Lai, Jie Li, Tingting Liao, Licheng Ji, Xinyao Hu and Kun Qian
    Citation: Journal of Ovarian Research 2022 15:44
  7. To investigate the alterations of peripheral lymphocyte subpopulations in ovarian cancer patients compared to benign or borderline counterparts. The possible clinicopathological implications were also evaluated.

    Authors: Shuang Ye, Wei Chen, Yuwei Zheng, Yutuan Wu, Libing Xiang, Teng Li, Bo Ping, Xiaoming Zhang and Huijuan Yang
    Citation: Journal of Ovarian Research 2022 15:43
  8. Resistant ovary syndrome (ROS) is a rare endocrine disorder and there have been few reports of live births by affected patients. As gonadotropin resistance leads immature oocytes, some researchers reported few...

    Authors: Huiying Li, Tianli Chang, Hongbei Mu and Wenpei Xiang
    Citation: Journal of Ovarian Research 2022 15:42
  9. Ovarian “seromucinous carcinoma” has been recently removed in 2020 5th Edition of WHO classification of Female Genital Tumors and is considered as a subtype of endometrioid carcinoma with mucinous differentiation...

    Authors: Bo Seong Yun, Seyeon Won, Ju-Hyun Kim, Nara Lee, Miseon Kim, Mi Kyoung Kim, Mi-La Kim, Yong Wook Jung, Ji Young Kim, Seok Ju Seong and Eunah Shin
    Citation: Journal of Ovarian Research 2022 15:41
  10. Polycystic ovary syndrome (PCOS) is an endocrine disease associated with reproduction. The Cuscuta-Salvia formula has been widely used to treat for PCOS in clinic. However, its chemical and pharmacological proper...

    Authors: Ying-ying Zhang, Jian-xiong Ma, Yu-tian Zhu, Yi-xuan Wang, Wang-qiang Chen, Xin Sun, Wei Zhang, Chen-ye Wang and Cai-fei Ding
    Citation: Journal of Ovarian Research 2022 15:40
  11. Ovarian cancer (OC) is the deadliest tumor in the female reproductive tract. And increased resistance to platinum-based chemotherapy represents the major obstacle in the treatment of OC currently. Robust and a...

    Authors: Siyu Chen, Yong Wu, Simin Wang, Jiangchun Wu, Xiaohua Wu and Zhong Zheng
    Citation: Journal of Ovarian Research 2022 15:39
  12. Oocyte maturation arrest at metaphase I leads to fertilization failure in humans. In early embryos, the tubulin beta 8 class VIII (TUBB8) encodes a β-tubulin isotype and aids in the assembling of the human oocyte...

    Authors: Zhongyuan Yao, Jun Zeng, Huimin Zhu, Jing Zhao, Xiaoxia Wang, Qiuping Xia, Yanping Li and Lingqian Wu
    Citation: Journal of Ovarian Research 2022 15:38
  13. We recently published evidence to suggest that two populations of stem cells including very small embryonic-like stem cells (VSELs) and ovarian stem cells (OSCs) in ovary surface epithelium (OSE) undergo proli...

    Authors: Diksha Sharma and Deepa Bhartiya
    Citation: Journal of Ovarian Research 2022 15:37

    The Correction to this article has been published in Journal of Ovarian Research 2023 16:165

  14. What influence does seven days of oestrogen administration versus fourteen days have on the reproductive outcomes of frozen-thawed embryo transfer (FET) in programmed endometrial preparation cycles?

    Authors: Wen-Jing Jiang, Jing-Yan Song and Zhen-Gao Sun
    Citation: Journal of Ovarian Research 2022 15:36
  15. Brain-derived neurotrophic factor (BDNF) is a known regulator of the development and maintenance of chronic pain in various chronic disorders. Together with its high-affinity tyrosine kinase type B (TrKB) rece...

    Authors: Sha Wang, Hua Duan, Bohan Li, Wei Hong, Xiao Li, Yiyi Wang and Zheng Chen Guo
    Citation: Journal of Ovarian Research 2022 15:35
  16. The mammalian follicle is the basic functional unit of the ovary, and its normal development is required to obtaining oocytes capable of fertilization. As women get older or decline in ovarian function due to ...

    Authors: Huiying Fan, Jiahuan He, Yucheng Bai, Qina He, Tongwei Zhang, Junya Zhang, Guang Yang, Ziwen Xu, Jingyi Hu and Guidong Yao
    Citation: Journal of Ovarian Research 2022 15:34
  17. Ovarian endometrioma is a common gynecologic disease among reproductive-aged women. Pregnancy-related hormonal status may lead to changes of decidualization, which may resemble ovarian malignancies in sonograp...

    Authors: Min Yin, Tao Wang, Sijian Li, Xinyue Zhang and Jiaxin Yang
    Citation: Journal of Ovarian Research 2022 15:33
  18. Ovarian cancer is one of the most lethal malignancies, with a 1.9% mortality rate worldwide. The dysregulation of the FEN1 gene and miR-4324 has been associated with cancer progression. However, the relationship ...

    Authors: Haixia Wu, Youliang Yan, Jialin Yuan, Mengze Luo and Yingjian Wang
    Citation: Journal of Ovarian Research 2022 15:32
  19. Premature ovarian insufficiency (POI) plagues 1% of women under 40, while quite a few remain an unknown cause. The development of sequencing has helped find pathogenic genes and reveal the relationship between...

    Authors: Jie Li, Tianliu Peng, Le Wang, Panpan Long, Ruping Quan, Hangjing Tan, Minghua Zeng, Xue Wu, Junting Yang, Hongmei Xiao and Xiaobo Shi
    Citation: Journal of Ovarian Research 2022 15:31
  20. Accumulating evidence suggests a strong association between polycystic ovary syndrome (PCOS) and ovarian cancer (OC), but the potential molecular mechanism remains unclear. In this study, we identified previou...

    Authors: Juan Zou, Yukun Li, Nianchun Liao, Jue Liu, Qunfeng Zhang, Min Luo, Jiao Xiao, Yanhua Chen, Mengjie Wang, Kexin Chen, Juan Zeng and Zhongcheng Mo
    Citation: Journal of Ovarian Research 2022 15:30
  21. Measurement of serum CA125, an antigenic fragment of human mucin 16 (MUC16), is used to monitor the clinical progression of epithelial ovarian cancer (EOC). However, rather than simply a passive marker reflect...

    Authors: Kornél Lakatos, Germán González, Jawad Hoballah, Jeff Brooker, Sinyoung Jeong, Conor Evans, Petra Krauledat, W. Peter Hansen, Kevin M. Elias, Manish Patankar, Vilmos Fülöp, Panagiotis A. Konstantinopoulos and Daniel W. Cramer
    Citation: Journal of Ovarian Research 2022 15:28
  22. Ovarian cancer (OC) is one of the serious threats to the health of women worldwide, and accurate biomarkers are urgently demanded for early diagnosis of OC. We have previously confirmed that miR-205 promotes t...

    Authors: Zehua Zhu, Zhaojun Chen, Mingxing Wang, Min Zhang, Yiwen Chen, Xiao Yang, Changjun Zhou, Yuhua Liu, Liquan Hong and Lahong Zhang
    Citation: Journal of Ovarian Research 2022 15:27
  23. Ovarian mucinous carcinoma is a disease that requires unique treatment. But for a long time, guidelines for ovarian serous carcinoma have been used for the treatment of ovarian mucinous carcinoma. This study a...

    Authors: Li Yang, Jinfen Yu, Shuang Zhang, Yisi Shan, Yajun Li, Liugang Xu, Jinhu Zhang and Jianya Zhang
    Citation: Journal of Ovarian Research 2022 15:26
  24. Recently, long non-coding RNAs (lncRNAs) and microRNAs (miRNAs) have been identified as essential biomarkers during development of malignancies. This study was performed to study the roles of lncRNA opa-intera...

    Authors: Yujue Wang, Lingling Li, Xun Zhang and Xiaolan Zhao
    Citation: Journal of Ovarian Research 2022 15:25
  25. Cervical cancer (CC) is the fourth aggressive tumor affecting women worldwide. Circular RNA (circRNA) is enrolled in CC process. This study aims to unveil the profiles of circ_101119 (circCDK17) in cell prolif...

    Authors: Rui Chen, Fei Liang, Jun Yan and Yu Wang
    Citation: Journal of Ovarian Research 2022 15:24
  26. MTHFD2 is a folate-coupled metabolic enzyme, which has been proved to participant in the metabolic reprogramming and tumor cell-sustaining proliferative capacity. However, the function of MTHFD2 in the develop...

    Authors: Xiangrong Cui, Huancheng Su, Jiaolin Yang, Xueqing Wu, Kai Huo, Xuan Jing and Sanyuan Zhang
    Citation: Journal of Ovarian Research 2022 15:23
  27. Ovarian cancer is the most women malignancy in the whole world. It is difficult to differentiate ovarian cancers from ovarian borderline tumors because of some similar imaging findings.Radiomics study may help...

    Authors: Xuefen Liu, Tianping Wang, Guofu Zhang, Keqin Hua, Hua Jiang, Shaofeng Duan, Jun Jin and He Zhang
    Citation: Journal of Ovarian Research 2022 15:22
  28. As the leading cancer of the female reproductive tract, it is not uncommon for human papilloma virus (HPV)-associated cervical squamous cell carcinoma (HPV-CSCC) to metastasize to pelvic organs and lymph nodes...

    Authors: Yuanyuan Zhang, Xiaobo Zhang, Huan Wang and Danhua Shen
    Citation: Journal of Ovarian Research 2022 15:21
  29. Growing evidence indicates that lncRNA colon cancer-associated transcript 2 (CCAT2) is associated with cancers. However, the clinical value of CCAT2 in cervical cancer (CC) remains unclear. In this study, seru...

    Authors: Xiaoli Cao, Juan Yao, Meiqun Jia, Xianjuan Shen, Jinye Zhang and Shaoqing Ju
    Citation: Journal of Ovarian Research 2022 15:20
  30. Tripartite Motif-Containing 24 (TRIM24) is a member of the tripartite motif family. TRIM24 is claimed aberrantly activated in a number of cancers, such as breast cancer, prostate cancer and lung cancer. Howeve...

    Authors: Liwei Zhang, Hong Chen, Baijuan Ding and Wei Jiang
    Citation: Journal of Ovarian Research 2022 15:19
  31. Despite the consistency of patient age, disease stage and treatment options, the prognosis of different high-grade serous ovarian carcinoma (HGSOC) patients is different. Here, we sought to measure predictive ...

    Authors: Hua Yang, Mei Yu, Sen Zhong, Yan You and Fengzhi Feng
    Citation: Journal of Ovarian Research 2022 15:18
  32. Spalt-like transcription factor 4 (SALL4) and aldehyde dehydrogenase1 family member A1 (ALDH1A1) expressing cells have been characterized as possessing stem cell-like properties known as cancer stem cell marke...

    Authors: Mina Sharbatoghli, Parisa Shamshiripour, Fahimeh Fattahi, Elham Kalantari, Zohre Habibi Shams, Mahshid Panahi, Mehdi Totonchi, Zeynab Asadi-Lari, Zahra Madjd and Leili Saeednejad Zanjani
    Citation: Journal of Ovarian Research 2022 15:17
  33. Ovarian cancer is the most deadly deadliest gynecological tumor in the female reproductive system. Therefore, the present study sought to determine the diagnostic performance of International Ovarian Tumor Ana...

    Authors: Wen ting Xie, Yao qin Wang, Zhi sheng Xiang, Zhong shi Du, Shi xin Huang, Yi jie Chen and Li na Tang
    Citation: Journal of Ovarian Research 2022 15:15
  34. This study aims to investigate the value of the quantitative indicators of MRI in the differential diagnoses of benign, borderline, and malignant epithelial ovarian tumors (EOTs).

    Authors: Fuxia Xiao, Lin Zhang, Sihua Yang, Kun Peng, Ting Hua and Guangyu Tang
    Citation: Journal of Ovarian Research 2022 15:13
  35. The five-year overall survival (OS) of advanced-stage ovarian cancer remains nearly 25-35%, although several treatment strategies have evolved to get better outcomes. A considerable amount of heterogeneity and...

    Authors: Akash Pawar, Oindrila Roy Chowdhury, Ruby Chauhan, Sanjay Talole and Atanu Bhattacharjee
    Citation: Journal of Ovarian Research 2022 15:12
  36. Melatonin, as a free radical scavenger exhibiting genomic actions, regulates the antioxidant genes expression and apoptosis mechanisms. In polycystic ovary syndrome (PCOS) patients, an imbalance between free r...

    Authors: Fatemeh Nikmard, Elham Hosseini, Mehrdad Bakhtiyari, Mahnaz Ashrafi, Fardin Amidi and Reza Aflatoonian
    Citation: Journal of Ovarian Research 2022 15:11
  37. Ferroptosis and iron-metabolism are regulated by Long non-coding RNAs (lncRNAs) in ovarian cancer (OC). Therefore, a comprehensive analysis of ferroptosis and iron-metabolism related lncRNAs (FIRLs) in OC is c...

    Authors: Songwei Feng, Han Yin, Ke Zhang, Mei Shan, Xuan Ji, Shanhui Luo and Yang Shen
    Citation: Journal of Ovarian Research 2022 15:10
  38. Cryopreservation of ovarian tissue is a fertility-preservation option for women before gonadotoxic treatments. However, cryopreserved ovarian tissue transplantation must be performed with caution in women with...

    Authors: Tristan Zver, Sophie Frontczak, Catherine Poirot, Aurélie Rives-Feraille, Brigitte Leroy-Martin, Isabelle Koscinski, Francine Arbez-Gindre, Francine Garnache-Ottou, Christophe Roux and Clotilde Amiot
    Citation: Journal of Ovarian Research 2022 15:9
  39. Long noncoding RNAs (lncRNAs) are important regulators of gene expression and can affect a variety of physiological processes. Recent studies have shown that immune-related lncRNAs play an important role in th...

    Authors: Yao Peng, Hui Wang, Qi Huang, Jingjing Wu and Mingjun Zhang
    Citation: Journal of Ovarian Research 2022 15:8
  40. High-grade serous ovarian cancer (HGSOC) is an aggressive gynaecological malignancy and associated with poor prognosis. Here we examined the effects of miR-625-3p on proliferation, treatment, migration and inv...

    Authors: Lili Zhong, Xiumin Liu, Lixing Wang, Yu Liu, Duohan Zhang and Yinlong Zhao
    Citation: Journal of Ovarian Research 2022 15:7
  41. Epithelial ovarian cancer (EOC) is the most malignant gynecological tumor in women. This study aimed to construct and compare radiomics-clinical nomograms based on MR images in EOC prognosis prediction.

    Authors: Tianping Wang, Haijie Wang, Yida Wang, Xuefen Liu, Lei Ling, Guofu Zhang, Guang Yang and He Zhang
    Citation: Journal of Ovarian Research 2022 15:6
  42. In recent years, the endometriosis has overcome a noteworthy renaissance in the recognition of its potential. In certain patients, a demonstrable malignant progression of ectopic foci leading to development of...

    Authors: Ján Varga, Alžbeta Reviczká, Hedviga Háková, Peter Švajdler, Miroslava Rabajdová and Alexander Ostró
    Citation: Journal of Ovarian Research 2022 15:5
  43. Polycystic ovary syndrome (PCOS) is an inflammatory endocrine-metabolic disorder related to reproductive system characterized by polycystic ovarian morphology, androgen excess, and chronic anovulation. Current...

    Authors: Somaye Falahatian, Raheem Haddad and Nafiseh Pakravan
    Citation: Journal of Ovarian Research 2022 15:4
  44. Progestin-primed ovarian stimulation (PPOS) has been used in infertility cases in recent years, and several reports have stated that it has oocyte collection results similar to those of gonadotropin-releasing ...

    Authors: Haipeng Huang, Yukiko Itaya, Kouki Samejima, Shunichiro Ichinose, Tatsuya Narita, Shigetaka Matsunaga, Masahiro Saitoh and Yasushi Takai
    Citation: Journal of Ovarian Research 2022 15:2

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.